Related Experiment Videos

Reactive microglia specifically associated with amyloid plaques in Alzheimer's disease brain tissue express

W A Jefferies1, M R Food, R Gabathuler

  • 1Biotechnology Laboratory, University of British Columbia, Vancouver, Canada.

Brain Research
|March 11, 1996
PubMed

Insights

Melanotransferrin, a novel iron uptake pathway, may play a role in Alzheimer's disease (AD) pathology. This protein was found in specific brain cells, suggesting a new target for AD research.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • Metals, particularly iron, are implicated in neuropathologies.
  • Disruptions in iron metabolism and transport are evident in Alzheimer's disease (AD).
  • A novel iron uptake pathway involving melanotransferrin (p97), independent of the transferrin receptor, has been identified.

Purpose of the Study:

  • To investigate the potential link between melanotransferrin and Alzheimer's disease (AD) pathology.
  • To examine the distribution of melanotransferrin, transferrin, and the transferrin receptor in AD brain tissues.

Main Methods:

  • Immunohistochemical analysis of brain tissues from AD cases.
  • Localization studies of melanotransferrin, transferrin, and transferrin receptor.

Main Results:

  • In AD brain tissues, melanotransferrin and the transferrin receptor were highly localized to capillary endothelium.
  • Transferrin was primarily found in glial cells.
  • Melanotransferrin was also detected in reactive microglia associated with senile plaques in AD brains.

Conclusions:

  • Melanotransferrin mediates iron uptake via a pathway distinct from the transferrin receptor.
  • This melanotransferrin-mediated iron uptake pathway may contribute to the pathology of Alzheimer's disease.

Related Concept Videos